WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 19, 2008, 28(47):12570-12580; doi:10.1523/JNEUROSCI.4048-08.2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seah, C.
Right arrow Articles by Bérubé, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seah, C.
Right arrow Articles by Bérubé, N. G.

 Previous Article  |  Next Article 

Neurobiology of Disease
Neuronal Death Resulting from Targeted Disruption of the Snf2 Protein ATRX Is Mediated by p53

Claudia Seah,1,2,4 * Michael A. Levy,2,4 * Yan Jiang,1,2,4 Sulayman Mokhtarzada,2 Douglas R. Higgs,3 Richard J. Gibbons,3 and Nathalie G. Bérubé1,2,4

Departments of 1Paediatrics and 2Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada N6C 2V5, 3Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom, and 4Children's Health Research Institute, Lawson Health Research Institute, London, Ontario, Canada N6C 2V5

Correspondence should be addressed to Nathalie G. Bérubé, Victoria Research Laboratories, 800 Commissioners Road East, London, Ontario, Canada N6C 2V5. Email: nberube{at}uwo.ca

ATRX, a chromatin remodeling protein of the Snf2 family, participates in diverse cellular functions including regulation of gene expression and chromosome alignment during mitosis and meiosis. Mutations in the human gene cause alpha thalassemia mental retardation, X-linked (ATR-X) syndrome, a rare disorder characterized by severe cognitive deficits, microcephaly and epileptic seizures. Conditional inactivation of the Atrx gene in the mouse forebrain leads to neonatal lethality and defective neurogenesis manifested by increased cell death and reduced cellularity in the developing neocortex and hippocampus. Here, we show that Atrx-null forebrains do not generate dentate granule cells due to a reduction in precursor cell number and abnormal migration of differentiating granule cells. In addition, fewer GABA-producing interneurons are generated that migrate from the ventral telencephalon to the cortex and hippocampus. Staining for cleaved caspase 3 demonstrated increased apoptosis in both the hippocampal hem and basal telencephalon concurrent with p53 pathway activation. Elimination of the tumor suppressor protein p53 in double knock-out mice rescued cell death in the embryonic telencephalon but only partially ameliorated the Atrx-null phenotypes at birth. Together, these findings show that ATRX deficiency leads to p53-dependent neuronal apoptosis which is responsible for some but not all of the phenotypic consequences of ATRX deficiency in the forebrain.

Key words: dentate gyrus; GABAergic neurons; migration; apoptosis; p53; ATRX; brain development; X-linked mental retardation


Received Aug. 24, 2008; accepted Oct. 13, 2008.

Correspondence should be addressed to Nathalie G. Bérubé, Victoria Research Laboratories, 800 Commissioners Road East, London, Ontario, Canada N6C 2V5. Email: nberube{at}uwo.ca






-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-